Literature DB >> 18181717

Development of probiotics as biologic drugs.

Freddie Ann Hoffman1.   

Abstract

In the United States, probiotics that are intended to be used to diagnose, cure, mitigate, treat, or prevent disease in humans or other animals and that affect the structure or the function of the body are considered to be drugs. This article provides a brief overview of the historical basis of US regulation of drugs and biologics and explores the legal, regulatory, and policy considerations for probiotics as biologic drugs for humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181717     DOI: 10.1086/523326

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.

Authors:  V Sreeja; Jashbhai B Prajapati
Journal:  Probiotics Antimicrob Proteins       Date:  2013-06       Impact factor: 4.609

Review 2.  Probiotics in human health and disease: from nutribiotics to pharmabiotics.

Authors:  Eun-Sook Lee; Eun-Ji Song; Young-Do Nam; So-Young Lee
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

Review 3.  Evidence-based guidelines for use of probiotics in preterm neonates.

Authors:  Girish C Deshpande; Shripada C Rao; Anthony D Keil; Sanjay K Patole
Journal:  BMC Med       Date:  2011-08-02       Impact factor: 8.775

4.  Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents.

Authors:  Anita Sainsbury; Alexander C Ford
Journal:  Therap Adv Gastroenterol       Date:  2011-03       Impact factor: 4.409

Review 5.  A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB.

Authors:  Vanessa Liévin-Le Moal
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 6.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

7.  Anti-Colorectal Cancer Effects of Probiotic-Derived p8 Protein.

Authors:  Byung Chull An; Sunwoong Hong; Ho Jin Park; Bong-Kyu Kim; Jun Young Ahn; Yongku Ryu; Jae Hyung An; Myung Jun Chung
Journal:  Genes (Basel)       Date:  2019-08-19       Impact factor: 4.096

Review 8.  Obesity as a consequence of gut bacteria and diet interactions.

Authors:  Katerina Kotzampassi; Evangelos J Giamarellos-Bourboulis; George Stavrou
Journal:  ISRN Obes       Date:  2014-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.